Rosseti Center's RAS net profit for 9 months of 2023 amounted to ₽6.41 billion, up 79.5% from ₽3.571 billion in the previous year. Revenue rose 13.4% to ₽87.758 billion against ₽77.404 billion a year earlier.
Rosseti Center and Volga Region's RAS net profit for 9 months of 2023 amounted to ₽11.888 billion, up 44.2% from ₽8.244 billion in the previous year. Revenue rose 14.9% to ₽92.722 billion against ₽80.697 billion a year earlier.
Nauka-Svyaz's RAS net profit for 9 months of 2023 amounted to ₽732,000, up 11 times from ₽66,000 in the previous year. Revenue increased 7.8% to ₽48,306 million vs. ₽44,793 million a year earlier.
TNS Energy Kuban's RAS net profit for 9 months of 2023 amounted to ₽5.831 billion, up 17.4 times from ₽0.335 billion in the previous year. Revenue rose 15.6% to ₽60.763 billion against ₽52.542 billion a year earlier.
Perm Power Supply Company's RAS net profit for 9 months of 2023 amounted to ₽942.75 million, up 36.9% from ₽688.87 million in the previous year. Revenue rose 9.1% to ₽32.782 billion against ₽30.041 billion a year earlier.
Amgen's GAAP net income for 9 months of 2023 was $5.95 billion, up 20.4% from $4.94 billion in the prior year. Revenue increased by 2.6% to $19.994 bln vs. $19.484 bln a year earlier.
Pfizer's GAAP net income for 9 months of 2023 amounted to $5.518 billion, down 4.8 times from $26.404 billion in the previous year. Revenue declined 41.8% to $44.247 billion from $76.04 billion a year earlier.
Caterpillar's GAAP net income for 9 months of 2023 totaled $7.659 billion, up 45.9% from $5.25 billion in the prior year. Revenues increased 16.7% to $49.99 billion versus $42.83 billion a year earlier.
UTair's RAS net profit for 9 months of 2023 amounted to ₽6.307 billion, up 39.8% from ₽4.511 billion in the previous year. Revenue increased 15.5% to ₽55.554 billion against ₽48.086 billion a year earlier.